-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MLGxbxQ5ZDiqvXWbAm5uaxPJg6N1Z9qEasdlHaeVWNPZ18d8hQpUFdQUpxpYXYlf m1G3rR+WyQ+HeR8Owvp+DQ== 0001209191-04-022134.txt : 20040427 0001209191-04-022134.hdr.sgml : 20040427 20040427164649 ACCESSION NUMBER: 0001209191-04-022134 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040426 FILED AS OF DATE: 20040427 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AMPER LINDA E CENTRAL INDEX KEY: 0001220024 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15190 FILM NUMBER: 04757457 MAIL ADDRESS: STREET 1: C/O OSI PHARMACEUTICALS INC STREET 2: 58 S SERVICE RD CITY: MELVILLE STATE: NY ZIP: 11747 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 58 SOUTH SERVICE RD. STREET 2: SUITE 110 CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 4 1 doc4.xml FORM 4 SUBMISSION X0202 4 2004-04-26 0 0000729922 OSI PHARMACEUTICALS INC OSIP 0001220024 AMPER LINDA E C/O OSI PHARMACEUTICALS, INC. 58 SOUTH SERVICE ROAD, SUITE 110 MELVILLE NY 11747 0 1 0 0 VP Bus. Administration & HR Common Stock 2004-04-26 4 M 0 467.0000 21.5500 A 467.0000 D Common Stock 2004-04-26 4 M 0 40000.0000 48.0000 A 40467.0000 D Common Stock 2004-04-26 4 S 0 1688.0000 80.5000 D 38779.0000 D Common Stock 2004-04-26 4 S 0 20218.0000 80.7000 D 18561.0000 D Common Stock 2004-04-26 4 S 0 5055.0000 80.9000 D 13506.0000 D Common Stock 2004-04-26 4 S 0 5217.0000 81.6066 D 8289.0000 D Common Stock 2004-04-26 4 S 0 8289.0000 82.3049 D 0 D Stock Option (Right to Buy) 21.5500 2004-04-26 4 M 0 467.0000 0 D 2003-06-12 2012-06-11 Common Stock 467.0000 6530.0000 D Stock Option (Right to Buy) 48.0000 2004-04-26 4 M 0 40000.0000 0 D 2002-04-16 2011-04-15 Common Stock 40000.0000 0 D One third of the stock option became exercisable one year after the date of the grant and the remainder vested ratably on a monthly basis over the succeeding 24 months. The stock option was granted pursuant to one of the Issuer's incentive and non-qualified stock option plans and is exempt under Rule 16b-3. Includes only options with the same termination date. Robert L. Van Nostrand by Power of Attorney 2004-04-27 -----END PRIVACY-ENHANCED MESSAGE-----